Novel Lipid-Lowering Therapies to Reduce Card...

Up next

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI, of University of Calgary Cumming School of Medicine joins JAMA Deputy Editor Kr ... Show more

. 28min 43sec

Medication Treatments for Alcohol Use Disorder

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss first-line pharmacotherapy for al ... Show more

. 20min 14sec

Recommended Episodes

Recent Clinical Advances in Reducing Risk for Dyslipidemia

Medscape InDiscussion: Dyslipidemia

In this episode, host Dr. Laurence Sperling speaks with Drs Erin Michos and Peter Toth about optimal use of newer dyslipidemia therapies. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958749). The topics and di ... Show more

. 23min 15sec

Cholesterol-lowering drug, Defibrillators, Post-traumatic stress disorder and heart disease, Lack of drugs in pregnancy

Inside Health

Statins have dominated the cholesterol-lowering field for some years but last week the results of an international trial of Evolocumab, one a new breed of medicines for reducing cholesterol, was hailed as a breakthrough. Professor Peter Sever, one of the leaders of the trial, exp ... Show more

. 27min 55sec

#361 Advanced Lipidology

The Curbsiders Internal Medicine Podcast

Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MDShow description: Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidolo ... Show more

. 1h 18min

The Latest Data on Lipid-Lowering Therapies for ASCVD and What it Means for Practicing Clinicians

Keeping Current

Are you up-to-date on the latest lipid-lowering therapies? Dr Ray provides an update.

Credit available for this activity expires: 12/27/23
Earn Credit / Learning Objectives & Disclosures:

. 25min 38sec